GlassScriptPhysician profile
Scott H Jones
NPI 1093745952
$4,808.85
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $973 · 2020: $1,129 · 2021: $1,523 · 2022: $1,184.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $875.32 | 2019-2022 | |
| Lundbeck LLC | $711.07 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $623.74 | 2019-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $489.74 | 2020-2022 | |
| Abbvie INC. | $372.29 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $363.51 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $262.37 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $221.11 | 2020-2022 | |
| Vanda Pharmaceuticals INC. | $184.36 | 2019-2021 | |
| Allergan, INC. | $153.70 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $139.54 | 2019-2022 | |
| Bausch Health US, LLC | $79.46 | 2020-2022 | |
| Ironshore Pharmaceuticals INC. | $78.79 | 2019-2022 | |
| Corium, LLC | $41.81 | 2022 | |
| Shire North American Group INC | $38.50 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $29.82 | 2022 | |
| Almatica Pharma LLC | $27.96 | 2021-2022 | |
| Adlon Therapeutics L.P. | $27.95 | 2019 | |
| Alkermes, INC. | $24.68 | 2022 | |
| Eisai INC. | $23.87 | 2020 | |
| Axsome Therapeutics, INC. | $20.04 | 2022 | |
| Supernus Pharmaceuticals, INC. | $19.22 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.